DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,367 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $400,880 | +9.7% | 1,616 | +6.2% | 0.02% | +6.2% |
| Q2 2023 | $365,296 | -7.1% | 1,521 | -2.3% | 0.02% | -11.1% |
| Q1 2023 | $393,025 | -6.5% | 1,557 | -1.6% | 0.02% | -10.0% |
| Q4 2022 | $420,393 | +8.3% | 1,582 | +5.5% | 0.02% | -16.7% |
| Q3 2022 | $388,000 | -0.8% | 1,500 | -2.5% | 0.02% | -17.2% |
| Q2 2022 | $391,000 | -14.6% | 1,539 | -1.5% | 0.03% | +26.1% |
| Q1 2022 | $458,000 | -6.1% | 1,563 | +5.5% | 0.02% | -4.2% |
| Q4 2021 | $488,000 | +8.0% | 1,482 | -0.1% | 0.02% | 0.0% |
| Q3 2021 | $452,000 | -66.4% | 1,483 | -70.4% | 0.02% | -55.6% |
| Q2 2021 | $1,344,000 | +129.0% | 5,005 | +91.7% | 0.05% | +107.7% |
| Q1 2021 | $587,000 | +96.3% | 2,611 | +94.0% | 0.03% | +85.7% |
| Q4 2020 | $299,000 | +6.8% | 1,346 | +3.3% | 0.01% | 0.0% |
| Q3 2020 | $280,000 | -16.2% | 1,303 | -30.8% | 0.01% | -22.2% |
| Q2 2020 | $334,000 | +61.4% | 1,882 | +39.2% | 0.02% | +80.0% |
| Q4 2019 | $207,000 | -42.8% | 1,352 | -45.9% | 0.01% | -41.2% |
| Q3 2019 | $362,000 | -8.6% | 2,499 | -9.9% | 0.02% | -15.0% |
| Q2 2019 | $396,000 | -84.1% | 2,774 | -85.3% | 0.02% | -82.9% |
| Q1 2019 | $2,485,000 | +27.9% | 18,810 | +0.0% | 0.12% | +18.2% |
| Q4 2018 | $1,943,000 | +545.5% | 18,802 | +398.7% | 0.10% | +266.7% |
| Q3 2017 | $301,000 | -65.7% | 3,770 | -63.7% | 0.03% | -57.8% |
| Q2 2017 | $877,000 | +250.8% | 10,391 | +255.9% | 0.06% | +204.8% |
| Q1 2017 | $250,000 | +13.6% | 2,920 | +3.1% | 0.02% | -4.5% |
| Q4 2016 | $220,000 | – | 2,831 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |